Vincerx Pharma, Inc. (VINC)
Vincerx Pharma has a market cap or net worth of $13.69 million. The enterprise value is -$4.55 million.
The last earnings date was Tuesday, November 14, 2023, before market open.
|Earnings Date||Nov 14, 2023|
Vincerx Pharma has 21.38 million shares outstanding. The number of shares has increased by 1.24% in one year.
|Shares Change (YoY)||+1.24%|
|Shares Change (QoQ)||+0.33%|
|Owned by Insiders (%)||25.96%|
|Owned by Institutions (%)||60.47%|
|EV / Earnings||n/a|
|EV / Sales||n/a|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
The company has a current ratio of 2.58, with a Debt / Equity ratio of 0.18.
|Debt / Equity||0.18|
|Debt / EBITDA||n/a|
|Debt / FCF||n/a|
Return on equity (ROE) is -160.10% and return on invested capital (ROIC) is -283.69%.
|Return on Equity (ROE)||-160.10%|
|Return on Assets (ROA)||-116.10%|
|Return on Capital (ROIC)||-283.69%|
|Revenue Per Employee||n/a|
|Profits Per Employee||-$1.19M|
|Effective Tax Rate||n/a|
Stock Price Statistics
The stock price has decreased by -1.91% in the last 52 weeks. The beta is 0.04, so Vincerx Pharma's price volatility has been lower than the market average.
|52-Week Price Change||-1.91%|
|50-Day Moving Average||0.91|
|200-Day Moving Average||1.12|
|Relative Strength Index (RSI)||34.62|
|Average Volume (30 Days)||50,847|
Short Selling Information
The latest short interest is 128,670, so 0.60% of the outstanding shares have been sold short.
|Short Previous Month||130,378|
|Short % of Shares Out||0.60%|
|Short % of Float||0.73%|
|Short Ratio (days to cover)||3.23|
|Earnings Per Share (EPS)||-$2.31|
The company has $20.87 million in cash and $2.77 million in debt, giving a net cash position of $18.11 million or $0.85 per share.
|Cash & Cash Equivalents||20.87M|
|Net Cash Per Share||$0.85|
|Equity / Book Value||15.74M|
|Book Value Per Share||0.74|
|Operating Cash Flow||-46.25M|
|Free Cash Flow||-46.25M|
|FCF Per Share||-$2.17|
Dividends & Yields
Vincerx Pharma does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
The average price target for Vincerx Pharma is $4.00, which is 524.81% higher than the current price. The consensus rating is "Strong Buy".
|Price Target Difference||524.81%|
|Analyst Consensus||Strong Buy|
|Revenue Growth Forecast (5Y)||n/a|
|EPS Growth Forecast (5Y)||-32.73%|
This stock does not have any record of stock splits.
|Last Split Date||n/a|